FIELD: chemistry.
SUBSTANCE: invention relates to the field of organic chemistry, specifically to a heterocyclic compound of formula (I) or a pharmaceutically acceptable salt thereof, where the 
component is 
or 
L1 represents -C(=O)-; L2 is a bond; m is selected from the group consisting of 1, 2, 3, and 4; R3 is 
each of R11, R12 is independently selected from the group consisting of F, Cl, Br, I, CN, C1-10-alkyl and C3-10-cycloalkyl, C1-10-alkyl and C3-10-cycloalkyl optionally substituted with zero, one, two or three R01; R01 selected from the group consisting of F, Cl, Br and I.
.
EFFECT: new benzofuran derivative has been obtained that is used as an NS4B inhibitor and is useful in treating the disease caused by the hepatitis C virus.
5 cl, 1 tbl, 68 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RESORCINOL DERIVATIVE AS HSP90 INHIBITOR | 2016 |
|
RU2697703C2 |
| FURAN-FUSED RING-SUBSTITUTED GLUTARIMIDE COMPOUND | 2022 |
|
RU2836921C1 |
| COUMARIN-LIKE CYCLIC COMPOUND AS MEK INHIBITOR AND USE THEREOF | 2018 |
|
RU2742234C1 |
| DERIVATIVE WITH ARTICULATED RINGS AND METHOD FOR PREPARATION THEREOF, INTERMEDIATE COMPOUND, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | 2016 |
|
RU2683566C1 |
| PDE4 INHIBITOR | 2017 |
|
RU2743126C2 |
| ANTI-VIRAL COMPOSITIONS OF WIDE SPECTRUM OF ACTION AND METHODS | 2018 |
|
RU2813125C2 |
| QUINOLINE DERIVATIVES AS SMO INHIBITORS | 2015 |
|
RU2695815C2 |
| HYDROXYPURINE COMPOUNDS AND WAYS OF THEIR USE | 2015 |
|
RU2673458C1 |
| REGULATOR BASED ON NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2020 |
|
RU2829553C2 |
| CONDENSED TRICYCLIC COMPOUND AS DOUBLE INHIBITOR OF PDE3/PDE4 | 2019 |
|
RU2827863C2 |
